AMPLATZER Duct Occluder II Additional Sizes

A trial with no phase registered on ClinicalTrials.gov. The registry status is completed. It enrolled 200 participants.

Also called NCT03055858

  • Study
  • In this atlas

Overview

Design
Interventional study; allocation not applicable; no masking; primary purpose treatment
Phase
Not applicable
Enrolled
  • 200 participants (enrolled count) (from the registry)
Sponsor
  • Abbott Registry lists this organization as the lead sponsor
Registry
  • NCT NCT03055858
Started
(actual) (from the registry)
Primary completion
(actual) (from the registry)
Completion
(actual) (from the registry)
Results first posted
(from the registry)
Countries
United States (from the registry)
Registry status
  • Completed (from the registry)

Technical summary

Registry record NCT03055858. Allocation not applicable; no masking; primary purpose treatment. Start 2017-06-05 (actual); primary completion 2019-09-25 (actual). Results posted on 2020-10-05.

The registry's words

Labels as the registry gives them, not rewritten.

Brief title
AMPLATZER Duct Occluder II Additional Sizes
Acronym
ADO II AS
Condition
Patent Ductus Arteriosus
Intervention (Device)
ADO II AS (PDA closure)
Lead sponsor
Abbott Medical Devices (class: industry)

Record details

Record id
cardio:ct-nct03055858
Content hash
19fb927ffb723e915f9abb7fd6a69dcaa89784041811787233d788f2f00ba5e1